Loading...
Depleting Tumor Cells Expressing Immune Checkpoint Ligands—A New Approach to Combat Cancer
Antibodies against inhibitory immune checkpoint molecules (ICPMs), referred to as immune checkpoint inhibitors (ICIs), have gained a prominent place in cancer therapy. Several ICIs in clinical use have been engineered to be devoid of effector functions because of the fear that ICIs with preserved ef...
Na minha lista:
| Udgivet i: | Cells |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8069236/ https://ncbi.nlm.nih.gov/pubmed/33921301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10040872 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|